Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001477932-24-006299
Filing Date
2024-10-09
Accepted
2024-10-09 13:08:30
Documents
119
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A avrw_10qa.htm   iXBRL 10-Q/A 1613407
2 CERTIFICATION avrw_ex311.htm EX-31.1 13542
3 CERTIFICATION avrw_ex312.htm EX-31.2 13646
4 CERTIFICATION avrw_ex321.htm EX-32.1 5498
5 CERTIFICATION avrw_ex322.htm EX-32.2 5385
  Complete submission text file 0001477932-24-006299.txt   9673171

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA avrw-20210630.xsd EX-101.SCH 120327
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE avrw-20210630_lab.xml EX-101.LAB 579227
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avrw-20210630_cal.xml EX-101.CAL 82053
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avrw-20210630_pre.xml EX-101.PRE 496490
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avrw-20210630_def.xml EX-101.DEF 294793
123 EXTRACTED XBRL INSTANCE DOCUMENT avrw_10qa_htm.xml XML 1769950
Mailing Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411
Business Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411 424-273-8675
Avenir Wellness Solutions, Inc. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55908 | Film No.: 241362227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)